Correction to: EGFR Targeted Paclitaxel and Piperine Co-loaded Liposomes for the Treatment of Triple Negative Breast Cancer (AAPS PharmSciTech, (2020), 21, 5, (151), 10.1208/s12249-020-01671-7)

dc.contributor.author	Burande, A.S.
dc.contributor.author	Viswanadh, M.K.
dc.contributor.author	Jha, A.
dc.contributor.author	Mehata, A.K.
dc.contributor.author	Shaik, A.
dc.contributor.author	Agrawal, N.
dc.contributor.author	Poddar, S.
dc.contributor.author	Mahto, S.K.
dc.contributor.author	Muthu, M.S.
dc.date.accessioned	2020-10-15T10:10:27Z
dc.date.available	2020-10-15T10:10:27Z
dc.date.issued	2020-08-01
dc.identifier.issn	1530-9932
dc.identifier.uri	http://localhost:8080/xmlui/handle/123456789/816
dc.description.abstract	As the authors were working on similar projects on liposomes at the same time, the 3D figures of Fig. 3 bi and Fig. 3 bii were inadvertently misplaced. © 2020, American Association of Pharmaceutical Scientists.	en_US
dc.language.iso	en_US	en_US
dc.publisher	Springer	en_US
dc.relation.ispartofseries	AAPS PharmSciTech;Vol. 21 Issue 6
dc.subject	EGFR Targeted Paclitaxel	en_US
dc.subject	Piperine Co-loaded	en_US
dc.subject	Triple Negative Breast Cancer	en_US
dc.subject	Treatment of Triple Negative Breast Cancer	en_US
dc.title	Correction to: EGFR Targeted Paclitaxel and Piperine Co-loaded Liposomes for the Treatment of Triple Negative Breast Cancer (AAPS PharmSciTech, (2020), 21, 5, (151), 10.1208/s12249-020-01671-7)	en_US
dc.type	Article	en_US